Evelo Biosciences, Inc.
EVLO · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $48 | $68 | $69 | $78 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $3 | $2 | $0 |
| Total Curr. Assets | $52 | $71 | $71 | $78 |
| Property Plant & Equip (Net) | $12 | $16 | $18 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $4 | $5 |
| Total NC Assets | $13 | $17 | $22 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $64 | $88 | $91 | $91 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $1 | $1 |
| Short-Term Debt | $2 | $2 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $13 | $0 | $0 |
| Other Curr. Liab. | $8 | $1 | $18 | $9 |
| Total Curr. Liab. | $12 | $17 | $20 | $10 |
| LT Debt | $49 | $54 | $40 | $20 |
| Deferred Rev, NC | $8 | $8 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $0 | $1 |
| Total NC Liab. | $57 | $62 | $40 | $21 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $8 | $10 | $0 |
| Total Liabilities | $69 | $79 | $60 | $31 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $91 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$529 | -$415 | -$293 | -$199 |
| AOCI | $0 | $0 | $0 | -$91 |
| Other Equity | $524 | $423 | $323 | $259 |
| Total Equity | -$5 | $9 | $30 | $60 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $64 | $88 | $91 | $91 |
| Net Debt | $3 | -$12 | -$29 | -$58 |